Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2 by Ballinger, Megan N et al.
RESEARCH Open Access
Impaired neonatal macrophage phagocytosis is
not explained by overproduction of
prostaglandin E2
Megan N Ballinger*, Marc Peters-Golden and Bethany B Moore
Abstract
Background: Neonates and young infants manifest increased susceptibility to bacterial, viral and fungal lung
infections. Previous work has identified a role for eicosanoids in mediating host defense functions of macrophages.
This study examines the relationship between alveolar macrophage (AM) host defense and production of lipid
mediators during the neonatal period compared to adult AMs.
Methods: AMs were harvested from young (day 7 and day 14) and adult (~10 week) rats. The functionality of
these cells was assessed by examining their ability to phagocytose opsonized targets, produce cytokines,
eicosanoids and intracellular cAMP measured by enzyme immunoassays, and gene expression of proteins, enzymes
and receptors essential for eicosanoid generation and phagocytosis measured by real time RT-PCR.
Results: AMs from young animals (day 7 and 14) were defective in their ability to phagocytose opsonized targets
and produce tumor necrosis factor (TNF)- a. In addition, young AMs produce more prostaglandin (PG) E2, a
suppressor of host defense, and less leukotriene (LT) B4, a promoter of host defense. Young AMs express higher
levels of enzymes responsible for the production of PGE2 and LTB4; however, there was no change in the
expression of E prostanoid (EP) receptors or LT receptors. Despite the similar EP profiles, young AMs are more
responsive to PGE2 as evidenced by their increased production of the important second messenger, cyclic AMP. In
addition, young AMs express higher levels of PDE3B and lower levels of PDE4C compared to adult AMs. However,
even though the young AMs produced a skewed eicosanoid profile, neither the inhibition of PGE2 by aspirin nor
the addition of exogenous LTB4 rescued the defective opsonized phagocytosis. Examination of a receptor
responsible for mediating opsonized phagocytosis showed a significant decrease in the gene expression levels of
the Fcgamma receptor in young (day 7) AMs compared to adult AMs.
Conclusion: These results suggest that elevated production of PGE2 and decreased production of LTB4 do not
contribute to impaired opsonized macrophage phagocytosis and highlight an important difference between young
and adult AMs.
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Background
Lung infections account for more global burden of dis-
ease than any other category, including AIDS, cancer,
ischemic cardiovascular disease and diarrheal diseases
[1]. Due to the risk of infection from a myriad of micro-
organisms, the lung has developed an efficient host
defense system to protect itself. In a naïve,
uncompromised host, resident alveolar macrophages
(AMs) are thought to be the primary cell involved in
the recognition, ingestion, and eventual destruction of
pathogens. AMs phagocytose antibody opsonized patho-
gens via engagement of their Fcg receptors.
Children, particularly neonates and young infants,
have an altered immune system, increasing their sus-
ceptibility to infections, many of which involve the lung.
Although the total number of AMs in newborn lungs is
slightly less than in adults, it is more likely that the
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functional immaturity of the AMs in neonates results in
the enhanced susceptibility to infection [2]. Animal
models have shown that young AMs are defective in
both opsonized [3] and unopsonized [4-6] phagocytosis
and killing [3] compared to AMs from an adult. While
it is generally accepted that newborns are more vulner-
able to infectious insult it is not known whether this
relates to differences in phagocytic receptors on innate
immune cells or alterations in soluble mediators.
Secreted mediators are important regulators of the host
immune response to infection. Eicosanoids are lipid med-
iators which are synthesized and secreted by virtually all
cell types and are capable of eliciting a wide spectrum of
biological responses [7]. Two classes of eicosanoids that
mediate host defense function are leukotrienes (LTs) and
prostaglandins (PGs). LTs, consisting of both leukotriene
B4 (LTB4) and cysteinyl leukotrienes (LTC4, LTD4, and
LTE4), augment bacterial phagocytosis and killing by AMs
[8]. LTs exert their antimicrobial functions by ligating dif-
ferent G-protein coupled receptors (GPCRs) known as B
leukotriene type (BLT) 1 and 2 receptor and cysteinyl LT
type 1 (cysLT1) and 2 receptor. By contrast, PGE2 is an
important negative regulator of host innate immunity,
with the ability to inhibit AM phagocytosis and killing [9].
PGE2 signals through four different GPCRs, termed E
prostanoid (EP) receptors 1-4, to effect intracellular signal-
ing pathways, such as cyclic AMP (cAMP) [10]. Interest-
ingly, overproduction of PGE2 and/or underproduction of
LTs have been shown to negatively regulate host defense
function in a variety of immunosuppressed states, includ-
ing: cancer, HIV infection, malnutrition, and stem cell and
solid organ transplant recipients [11].
Previous work has examined the role of eicosanoids in
regulating host defense function during aging. Thus far,
two studies have found elevated PGE2 production and
decreased LTs by newborn macrophages compared to
adults [12,13]. Interestingly, elevated cAMP levels were
also found in mononuclear cells isolated from neonates
[14]. These studies suggested that the eicosanoid imbalance
in neonates could explain the impaired AM function. Our
current studies set out to definitively test this hypothesis.
Interestingly, while our results verified the eicosanoid
imbalance in AMs from young versus adult animals, we
could not demonstrate that eicosanoids regulated the func-
tion of AMs from young mice. Instead, our results suggest
that diminished expression of FcgR may contribute.
Methods
Animals
Adult pathogen-free 125 to 150 g female (approximately
10 weeks of age) Wistar rats were obtained from Charles
River Laboratories. In addition, lactating dams with either
day 7 or day 14 female pups were also obtained from
Charles River. Animals were treated according to
National Institutes of Health guidelines for the use of
experimental animals, with approval of the University of
Michigan Committee for the Use and Care of Animals.
Alveolar macrophage isolation
Resident AMs were harvested as previously described [8]
although there were differences in the volumes used to
lavage each of the different age groups. A total of 5 ml
was used to lavage the day 7, 10 ml for the day 14, and
50 ml for the adult rats.
Opsonized phagocytosis assay
The ability of AMs to phagocytose an opsonized target
was performed as previously described [9]. Briefly, AMs
were harvested from each age group and plated at 2 ×
105 cells per well. The following days, AMs were washed
and treated with either Aspirin (Sigma), LTB4 (Cayman
Chemical) or vehicle control for 20 min before the addi-
tion of opsonized sheep red blood cells (RBCs) (ICN
Pharmaceuticals) at an MOI of 50:1 for 90 min. All non-
ingested RBCs were washed away with cold PBS and the
amount of internalization was assessed by microcoloro-
metric determination of intracellular hemoglobin.
Measurement of cytokines, eicosanoids, and intracellular
cAMP
AMs from different age groups were harvested and cul-
tured at 1 × 106 cells per well for 24 h with and without
LPS (500 ng, Sigma) or for 1 h with Ca2+ ionophore
A23187 (5 μM, Sigma) or for 15 min with PGE2 (1 μM,
Cayman Chemical). To measure cytokines or eicosa-
noids, the cell-free supernatants were collected and ana-
lyzed by specific ELISA for either TNF-a (R&D
systems) or LTB4 and PGE2 (Cayman Chemical). To
measure cAMP, cells were lysed in 0.1 M HCl for 20
min then intracellular cAMP levels were determined by
ELISA according to the manufacturer (Assay Designs).
Semi-quantitative real-time PCR
Semiquantitative real-time PCR was performed on an
ABI Prism 7000 thermocycler (Applied Biosystems).
Gene-specific primers were designed using Primer
Express software (PerkinElmer/PE Applied Biosystems)
and are shown in Table 1. Briefly, the reaction mixture
contained 300 ng of cDNA, 12.5 μl of SYBR Green PCR
Master Mix (Applied Biosystems), and forward and
reverse primers at 300 nM. For each experiment, sam-
ples were run in triplicate. The average cycle threshold
(CT) was determined for each rat from a given experi-
ment. Relative gene expression (using the formula 2-
ΔΔCT) was calculated using the comparative CT method,
which assesses the difference in gene expression
between the gene of interest and an internal standard
gene (b-actin).
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Statistical analysis
Statistical significance was analyzed using Prism 3.0 sta-
tistical program (GraphPad Software). Comparisons
between two experimental groups were performed with
Student’s t test. Comparisons among three or more
experimental groups were performed with ANOVA and
a post hoc Bonferroni’s test to determine significance. A
value of p < 0.05 was considered significant
Results
Defective phagocytosis and proinflammatory cytokine
production from young AMs
Alveolar macrophages are the cell responsible for identi-
fication and clearance of pathogens from the lung. To
determine if the increased susceptibility in young rats
was due to a defect in these cells, AMs were harvested
from adult, day 14 and day 7 rats. We show that young
AMs were defective in their ability to ingest an opsonized
target (Figure 1A). In addition, AMs from young rats
(day 14 and 7) made reduced amounts of the pro-inflam-
matory cytokine TNF-a at baseline (Figure 1B). Interest-
ingly, when AMs from both young and adult rats were
maximally stimulated with LPS, there was no difference
in their ability to produce TNF-a (data not shown).
Alveolar macrophages from young rats produce a skewed
eicosanoid profile
There have been numerous diseases and conditions in
which the dysregulation of eicosanoids directly influ-
ences host defense functions [11]. AMs were harvested
from young and adult rats and the amount of eicosa-
noids produced were measured at baseline and when
maximally stimulated with LPS (to stimulate PGE2) or
with Ca2+ ionophore A23187 (to stimulate LTs). AMs
from day 7 rats made significantly more PGE2 at both
baseline and when maximally stimulated (Figure 2A and
2B). Unstimulated young AMs (both day 14 and day 7)
made significantly less LTB4 than adult AMs (Figure
2C). However, when maximally stimulated with Ca2+
ionophore, day 14 AMs make more LTB4 whereas day 7
AMs still produce less LTB4 (Figure 2D).
Dysregulation of enzymes and proteins associated with
eicosanoid production
There are several enzymes and proteins responsible for
the intracellular generation of PGs and LTs. In AMs
from day 7 rats, we observed a 5.8-fold increase in
Table 1 List of primers used for measuring gene
expression by real time PCR
Gene
name
Forward Primer Reverse Primer
b-actin CCTAAGGCCAACCGTGAAAA AGGGACAACACAGCCTGGAT
COX-1 GACCTGCCCCTATGTCTCCTT TCACGAAGACAGACCCGTCAT
COX-2 GGATCCCCAAGGCACAAATA CCTCGCTTCTGATCTGTCTTGA
5-LO GCTGCACAGAGTTGCCTAAGAA TCTAAACTGAGCTGCCGCTCTA
FLAP CCTTCGCTGGGCTGATGT TCTCCCAGATAGCCGACAAAGT
mPGEs-
1
AGGGTGCCATGTTTTCAGAG CAGTCTTTGGAGGAGCCAAG
EP1 AGCAGATGTGAGGGCAGAGT GCCTCATCCACTAGGCTCAG
EP2 CCTGGCCATTATGACCATCAC TCGGGAAGAGGTTTCATCCA
EP3 GTCTAGGCTTGCTGGCTCTG TGCGTCTTGCATTGCTCTAC
EP4 ACGCGGGCTTCAGTTCCT CGCACACCAGCACATTGC
BLT1 AGGATGCAGAAACGCTCTGT CGGTCCAGGCTCATGATAGT
cys-LT 1 GCCTCACCACCTATGCCTTA CCTGTGGAGGGCTCAAAACAT
Fcg
receptor
CCTGCAGAGTCCTGGCTTAC CTGATGACTGGGGACCAAAT
Figure 1 Decreased phagocytosis and TNF-a production from
young AMs compared to Adult AMs. AMs were harvested from
adult (~10 weeks old) and young (day 7 and 14) rats and allowed
to adhere overnight. A. AMs were given an opsonized target and
the amount of ingestion of the target was quantified after 90 mins.
Data represents the mean ± SEM from 4 independent experiments
preformed in quadruplicate (*p < 0.05 and **p < 0.01 when
compared to adult AMs). B. Supernatants were collected from AM
cultures and the amount of TNF-a was measured by a specific EIA.
Data shown are representative of three independent experiments
preformed in triplicate (***p < 0.001 when compared to adult AMs).
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mRNA encoding cyclooxygenase (COX)-2 and a 5.0-fold
increase in mPGE synthase-1, two inducible enzymes
responsible for PGE2 production (Figure 2E). In addi-
tion, there was no difference in expression of COX-1,
the enzyme responsible for basal PGE2 production, in
young AMs (data not shown). Despite the decrease in
LTB4 release by day 7 cells, there was no difference in
the expression of 5-lipoxygenase (5-LO) (Figure 2F).
Interestingly, there was actually an increase in the
expression of 5-LO in day 14 AMs. There was no signif-
icant difference in the mRNA expression of FLAP (5-
lipoxygenase activating protein), an accessory protein
necessary for LTB4 generation, in the young AMs com-
pared to adult (Figure 2F).
Increased sensitivity of young AMs to in vitro PGE2
stimulation
The generation of the secondary messenger cAMP has
important implications for intracellular signaling cas-
cades and is influenced in opposing fashion by PGE2 vs.
LTB4. Therefore, to determine if young AMs were cap-
able of increased cAMP generation, we measured the in
vitro production of this second messenger. We show a
slight increase (approximately 2-fold) in the baseline
level of cAMP by young AMs (Figure 3A). However,
when stimulated with PGE2, there was only a 2.2-fold
increase in cAMP production by adult AMs compared
to a 5.0-fold increase by day 14 AMs and a 4.8-fold
increase by day 7 AMs. Thus, in addition to elevated
PGE2 production and increased PG generating enzymes,
we also show that young AMs are more sensitive to
PGE2 signaling cascades.
Skewed PDE profile in young verses adult AMs
The level of cAMP in the cell is dependent on the activ-
ity of adenylyl cyclase (AC), the enzymes responsible for
converting ATP to cAMP, and the activity of PDEs, the
enzymes which degrade cAMP [15]. Previous work has
shown that PDE3 and PDE4 are the primary isoforms
Figure 2 Dysregulated eicosanoid production and expression
of enzymes and proteins responsible for eicosanoid generation
from young AMs compared to adult AMs. AMs were harvested
from adult (~10 weeks old) and young (day 7 and 14) rats and
allowed to adhere overnight. A. and B. Supernatants were collected
from AM cultures that were either unstimulated (A) or stimulated
with LPS (B, 500 ng) for 24 h. The amount of PGE2 was quantified
by specific EIA. C. and D. Supernatants were collected from AM
cultures either with media for 24 h (C) or with Ca2+ ionophore
A23187 (D, 5 μM) for 1 h. The amount of LTB4 was quantified by
specific EIA. E. and F. RNA was extracted from the cells, converted
into cDNA and the relative expression was determined using semi-
quantitative real-time PCR. The primers for specific genes of interest
are located in Table 1. For each sample, the expression of the gene
of interest was normalized to b-actin and the average of the adult
AMs was set to 1. For EIA, data shown are representative of three
independent experiments preformed at least in triplicate. For real
time PCR experiments, data represents the mean ± SEM of pooled
samples from 3 independent experiments. (*p < 0.05, **p < 0.01,
and p < 0.001 when compared to adult AMs).
Figure 3 Elevated cAMP and skewed PDE isoform expression
in neonatal macrophages. AMs were harvested from adult ((~10
weeks old) and young (day 7 and 14) rats and allowed to adhere
overnight. A. AMs were stimulated with media or 1 μM PGE2 for 20
min before lysing the cells. Intracellular cAMP levels were measured
in the whole cell lysate by specific EIA. For cAMP assay, data shown
are representative of three individual experiments at least in
preformed in duplicate. B. RNA was extracted from the cells,
converted to cDNA and the relative expression of each of the PDE3
and PDE4 isoforms was determined using semi-quantitative real-
time PCR. For real time PCR experiments, data represents mean ±
SEM of pooled samples from 3 independent experiments. (*p < 0.05
and ***p < 0.001 when compared to the unstimulated samples
(cAMP assay) and compared to adult AMs (real time PCR)).
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expressed in AMs [16]; therefore, we chose to examine
the relative gene expression of each of these enzymes in
AMs from young (day 7 and 14) compared to adult
AMs (Figure 3B). There was no difference in the expres-
sion of PDE4A, PDE4B, or PDE4D between the young
and the adult AMs (Figure 3B). However, we do show
that specifically young day 7 AMs express high levels of
PDE3B and low levels of PDE4C compared to adult AM
(Figure 3B). We were not able to detect expression of
PDE3A in any of the AMs tested (data not shown).
No difference in eicosanoid receptor gene expression in
young AMs
To determine if dysregulated eicosanoids influenced
expression of their receptors, we measured the amount
of GPCRs on young AMs. The relative amount of EP
receptor expression was found to be slightly different on
young AMs compared to adult AMs. The EP receptor
expression profile for adult rat AMs was EP2 > EP1 =
EP4 > EP3 compared to young AMs which was EP2 >
EP1 = EP3 > EP4. However, when levels of each recep-
tor were normalized and compared, there were no sta-
tistically significant changes (Figure 4A). There was a
6.2-fold increase in EP3, the Gi-coupled receptor,
expression in day 7 compared to adult, but interestingly,
this profile change did not diminish cAMP production
in response to PGE2 (Figure 3). Although there is a
trend toward elevated BLT1 (predominant LTB4 recep-
tor on AMs) and cysLT1 (predominant cysLT receptor
on AMs) expression on day 7 compared to adult, no sta-
tistically significant difference was measured (Figure 4B).
Thus, we conclude that overall, there was no difference
in receptor expression which could be linked to a func-
tional dysregulation of cAMP in young AMs.
Young AM phagocytosis is not influenced by modulation
of eicosanoids but does correlate with altered expression
of Fcg receptors
To determine whether the increased PGE2 or decreased
LTs contributed to defective AM function, we incubated
AMs from adult or young animals with either aspirin
(to inhibit PGs) or exogenous LTB4. As expected, treat-
ment with aspirin or exogenous LTB4 significantly aug-
mented the phagocytic ability of the adult AMs (Figure
5A and 5B). However, neither treatment was able to
enhance the phagocytic ability of young AMs from
either age group, suggesting that eicosanoid imbalances
were not responsible for the functional defects.
To determine whether differences in phagocytosis of
IgG-opsonized targets were due to a differential expres-
sion profile of phagocytic receptors, the expression of
the Fcg receptor (CD64) was examined in AMs from
young and adult rats. Day 7 young AMs had
significantly less Fcg receptor when compared to adult
AMs (Figure 5C).
Discussion
These studies examined the relationship between
macrophage host defense and eicosanoids during the
neonatal period. We demonstrate that AMs from young
animals (day 7 and day 14) have an impaired ability to
phagocytose opsonized targets and produce reduced
amounts of TNF-a at baseline. These studies also show
increased expression of enzymes responsible for PGE2
generation, but no change in EP receptor expression on
young macrophages. In addition, there was increased
expression of PDE3B and decreased expression of
PDE4C in young (day 7) AMs compared to adult AMs.
Although there was increased production of the
immuno-inhibitory eicosanoid PGE2, increased
Figure 4 No difference in eicosanoid receptor expression in
young AMs compared to adult AMs. AMs were harvested from
adult ((~10 weeks old) and young (day 7 and 14) rats. RNA was
extracted from the cells, converted into cDNA and the relative
expression was determined using semi-quantitative real-time PCR.
The primers for the specific genes of interest are located in Table 1.
For each sample, the expression of the gene of interest was
normalized to b-actin and the average of the adult AMs was set to
1. Data represents the mean ± SEM of pooled samples from 3
independent experiments.
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responsiveness to PGE2 and decreased production of the
immuno-stimulatory eicosanoid LTB4 in young AMs,
these changes did not influence the functionality of the
neonatal AMs. Rather, a possible explanation for the
discrepancy between eicosaniod production and phago-
cytic ability could be the decreased expression of Fcg
receptors on young (day 7) AMs. These results advance
the current understanding of the role of lipid mediators
in the functionality of neonatal AMs. Previously it was
assumed (by analogy to adult studies) that the elevated
production of PGE2 by neonatal AMs was responsible
for their impaired innate immune functions. Our results
demonstrate that this is not true and provide an impor-
tant framework for future therapeutic approaches to
treating babies with severe respiratory infections. Our
work suggests that neither COX inhibitors nor LT
receptor agonists will be effective therapies in this
patient population.
Part of the confusion associated with development lit-
erature is the definition of ‘young’ verses ‘old’ as well as
the type of model system employed. In some instances,
‘young’ refers to animals that are still nursing and only
hours or days old [3-6,17]; however in other cases
‘young’ refers to animals that are already weaned (4-6
weeks old). In this study we limited our focus to ‘young’
animals that are still nursing. The majority of the stu-
dies have been performed using rodent model systems;
however some work has been done using monkeys [5]
or cattle [12]. Although rodent studies are the simplest
and most cost effective system to employ, we recognize
that translating the data to humans is difficult due to
differences in life span and development [18]. Previous
work has shown that at birth, newborns have decreased
opsonins in their circulating blood compared to adults
which could diminish innate immune responses [19];
however this was normalized at 3 months of age. Based
on previous calculations [20], we believe that our rat
model reflects the > 3 month age of a human neonate.
Thus, we wanted to determine if there was an intrinsic
defect in AM function even in the situation where the
AMs are presented with equivalently opsonized parti-
cles. Additionally, opsonized phagocytosis by neonatal
AMs is an understudied area of investigation.
There have been conflicting reports regarding produc-
tion of extracellular mediators during the neonatal per-
iod. Previous work has shown that AMs from both
humans (< 2 years of age) [2] and newborn animals [21]
produce less TNF- a. However, other studies show that
neonatal AMs make similar amounts of pro-inflamma-
tory cytokines such as TNF-a, IL-1 IL-6, IL-12, and IL-
18 and chemoattractant cytokines such as MIP-1a and
MCP-1 [22,23]. Additionally, elevated production of the
immunosuppressive cytokine IL-10 was found in new-
born AMs [24]. Previous work has shown that PGE2 can
Figure 5 Modulation of eicosanoids did not alter phagocytosis
of young AMs. AMs were harvested from adult ((~10 weeks old)
and young (day 7 and 14) rats and allowed to adhere overnight. A
and B. AMs were either untreated or treated with 200 μM aspirin (A)
or 10 nM LTB4 (B) for 20 min before the addition of an opsonized
target. The amount of ingestion of the target was quantified after
90 mins. For phagocytosis assay, data are presented as the percent
of increase above baseline phagocytosis for each age group and
shown are the mean ± SEM from 3 independent experiments
preformed in triplicate. C. RNA was extracted from the cells,
converted into cDNA and the relative expression was determined
using semi-quantitative real-time PCR. For each sample, the
expression of Fcg receptor was normalized to b-actin and the
average of the adult AMs was set to 1. For real time PCR, data
represents the mean ± SEM of pooled samples from 3 independent
experiments (**p < 0.01 and ***p < 0.001 when untreated group).
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inhibit TNF-a [25] and increase IL-10 [26] in macro-
phages, therefore we investigated whether there were
differences in the production of this eicosanoid. Our
data show that young AMs produce increased PGE2. We
were able to demonstrate that the increased synthesis of
PGE2 in young AMs correlates with increased expres-
sion of the PGE2 synthetic enzymes, COX-2 and PGE-
syn-1.
As expected this enhanced PGE2 production corre-
lated with inhibition of TNF-a and diminished phagocy-
tosis. Surprisingly, we discovered that the inhibition of
PGs did not improve phagocytosis in the young AMs,
but aspirin treatment did enhance adult AM phagocyto-
sis. This result was quite unexpected and highlights a
unique difference in young versus adult AMs. Similarly,
young AMs produce decreased amounts of the pro-pha-
gocytic leukotriene, LTB4. The mechanistic basis for
decreased LTB4 expression is not clear as it did not cor-
relate precisely with expression of 5-LO or FLAP. Again,
addition of exogenous LTB4 had no effect on phagocyto-
sis by young AMs. These data highlight the unrespon-
siveness of young AMs to exogenous factors (both
positive and negative) that normally modulate phagocy-
tosis in adult AMs. It will be important to determine
whether this phenotype is specific to opsonized phago-
cytosis only, or if it also extends to non-opsonized pha-
gocytosis in future experiments.
To determine whether the unresponsiveness of young
AMs was due to receptor differences, we analyzed
expression of the 4 EP receptors and also that of the
main LTB4 receptor (BLT1) and the main cysteinyl leu-
kotriene receptor (Cys LT1) in young and adult AMs.
While there were slight differences in expression profiles
noted, none could explain the differential responsiveness
of young versus adult AMs. One result which was sur-
prising however, was that despite similarities in EP2
expression in adult and young AMs, the response of
young AMs to PGE2 stimulation was significantly
enhanced as evidenced by the increased generation of
cAMP in these cells. Since the receptor profiles sug-
gested that this was not due to increased EP2, we next
looked to determine whether differential expression of
PDEs could explain why cAMP would accumulate to
higher levels in young AMs. We found that young AMs
have higher expression of PDE3B and low levels of
PDE4C compared to adult AM. Previous work has
shown that PDE4 specific inhibitor suppresses TNF-a
whereas the PDE3 specific inhibitor did not [27]. There-
fore, we speculate that the lack of PDE4C allows for the
increased accumulation of cAMP thus leading to
decreased levels of TNF-a and impaired opsonized pha-
gocytosis. However, further work will need to be done
using PDE inhibitors (such as IBMX and rolipram) to
further dissect the mechanism for elevated cAMP
response and decreased Fc-mediated phagocytosis in
neonatal macrophages.
In addition to the cAMP differences, our work sug-
gests that the opsonized phagocytic defect in young
AMs may also relate to diminished Fcg receptor expres-
sion. Expression of Fcg receptor was significantly
decreased in day 7 AMs and trended towards a decrease
in day 14 AMs. Previous work has shown that neutro-
phils and monocytes isolated from neonates have
decreased Fcg receptor expression [28]. However, to our
knowledge this is the first report that AMs isolated
from neonates also have decreased Fcg receptor expres-
sion. Although our works shows there to be differences
in the mRNA expression of CD64 (FcRI), we recognize
that there are several other molecules important for
opsonized phagocytosis by macrophages including: FcRII
(CD32), FcRIII (CD16) and CD14. Additional work
needs to be done to examine the cell surface expression
and contribution of each of these molecules from the
various age groups to determine the impact on the pha-
gocytic ability of these cells.
In additional to differences in the expression of
receptors, it is also possible that, the inhibitory signal-
ing machinery downstream of EP2 may be inappropri-
ately coupled to Fcg in neonates. This may explain
why aspirin treatment did not benefit phagocytosis in
young AMs. In adult cells, PGE2 can inhibit opsonized
phagocytosis via activation of phosphatase and tensin
homolog deleted on chromosome 10 (PTEN) [29].
Thus, it is possible that PTEN activation is defective in
neonatal cells. Alternatively, activation of downstream
cAMP effector molecules, such as protein kinase A
(PKA) and exchange protein activated by cAMP (Epac)
may be impaired in neonatal AMs. Future studies will
be needed to determine whether the intracellular sig-
nals distal to cAMP are altered in neonates versus
adults.
Although differences in Fcg receptor expression likely
account for the defective phagocytosis phenotype in
vitro, we speculate that AM dysregulation may have
further important implications in host defense func-
tions of neonates in vivo. It is possible that the skewed
eicosanoid and cytokine profile of young AMs may
influence the functionality of other host defense cells
in vivo, such as neutrophils. Previous work has shown
that PGE2 can also inhibit host defense functions of
neutrophils [30]. Prior studies have found a decrease
in the total number of neutrophils recruited to the
lungs after an infection in young animals [23]. Our
findings of decreased LTB4 synthesis by young AMs
may explain a defect in neutrophil recruitment in vivo.
Thus, future studies will also examine the role of lipid
mediators in regulating host defense function of neu-
trophils during development.
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Conclusions
Taken together, our data confirm the observation that
neonatal AMs have defective host defense functions and
skewed eicosanoid synthetic patterns. This work pro-
vides new insight into the defective phagocytosis which
characterizes neonatal AMs. The defect in phagocytosis
can be explained in part by diminished Fcg receptor
expression, but it is not yet clear why young AMs are
functionally unresponsive to manipulation of prostaglan-
dins and leukotrienes These results suggest that neona-
tal AMs have additional, as yet unidentified,
mechanisms which limit their host-defense and make
them insensitive to pro- and anti-phagocytic effectors.
These studies highlight unique differences in young and
adult AMs and indicate that therapeutic strategies to
block PG production or enhance LT signaling to
improve AM function may be ineffective in very young
children. Studies of differentially regulated genes in neo-
natal and adult macrophages may uncover additional
pathways for further testing.
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